img

Global Malaria Drugs Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 420 | Industry : Medical Devices & Consumables Research Center

Publisher : MRX | Format : PDF

Global Malaria Drugs Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Malaria Drugs Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Malaria Drugs industry at home and abroad, estimate the overall market scale of the Malaria Drugs industry and the market share of major countries, Malaria Drugs industry, and study and judge the downstream market demand of Malaria Drugs through systematic research, Analyze the competition pattern of Malaria Drugs, so as to help solve the pain points of various stakeholders in Malaria Drugs industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Malaria Drugs Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Malaria Drugs Market?
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma
Kunming Pharmaceutical
Major Type of Malaria Drugs Covered in XYZResearch report
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Application Segments Covered in XYZResearch Market
Prevention
Treatment
Other

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Malaria Drugs Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Malaria Drugs Market by Value
2.2.1 Global Malaria Drugs Revenue by Type
2.2.2 Global Malaria Drugs Market by Value (%)
2.3 Global Malaria Drugs Market by Production
2.3.1 Global Malaria Drugs Production by Type
2.3.2 Global Malaria Drugs Market by Production (%)

3. The Major Driver of Malaria Drugs Industry
3.1 Historical & Forecast Global Malaria Drugs Demand
3.2 Largest Application for Malaria Drugs (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Malaria Drugs Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Malaria Drugs Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Malaria Drugs Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Malaria Drugs Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Malaria Drugs Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Malaria Drugs Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Malaria Drugs Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Malaria Drugs Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Malaria Drugs Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Malaria Drugs Average Price Trend
12.1 Market Price for Each Type of Malaria Drugs in US (2018-2022)
12.2 Market Price for Each Type of Malaria Drugs in Europe (2018-2022)
12.3 Market Price for Each Type of Malaria Drugs in China (2018-2022)
12.4 Market Price for Each Type of Malaria Drugs in Japan (2018-2022)
12.5 Market Price for Each Type of Malaria Drugs in India (2018-2022)
12.6 Market Price for Each Type of Malaria Drugs in Korea (2018-2022)
12.7 Market Price for Each Type of Malaria Drugs in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Malaria Drugs Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Malaria Drugs

14. Malaria Drugs Competitive Landscape
14.1 Cipla
14.1.1 Cipla Company Profiles
14.1.2 Cipla Product Introduction
14.1.3 Cipla Malaria Drugs Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Guilin Pharmaceutical
14.2.1 Guilin Pharmaceutical Company Profiles
14.2.2 Guilin Pharmaceutical Product Introduction
14.2.3 Guilin Pharmaceutical Malaria Drugs Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 IPCA Laboratories
14.3.1 IPCA Laboratories Company Profiles
14.3.2 IPCA Laboratories Product Introduction
14.3.3 IPCA Laboratories Malaria Drugs Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 GlaxoSmithKline
14.4.1 GlaxoSmithKline Company Profiles
14.4.2 GlaxoSmithKline Product Introduction
14.4.3 GlaxoSmithKline Malaria Drugs Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Mylan Labs
14.5.1 Mylan Labs Company Profiles
14.5.2 Mylan Labs Product Introduction
14.5.3 Mylan Labs Malaria Drugs Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Roche
14.6.1 Roche Company Profiles
14.6.2 Roche Product Introduction
14.6.3 Roche Malaria Drugs Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Novartis
14.7.1 Novartis Company Profiles
14.7.2 Novartis Product Introduction
14.7.3 Novartis Malaria Drugs Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Sanofi Aventis
14.8.1 Sanofi Aventis Company Profiles
14.8.2 Sanofi Aventis Product Introduction
14.8.3 Sanofi Aventis Malaria Drugs Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Ajanta Pharma
14.9.1 Ajanta Pharma Company Profiles
14.9.2 Ajanta Pharma Product Introduction
14.9.3 Ajanta Pharma Malaria Drugs Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Kunming Pharmaceutical
14.10.1 Kunming Pharmaceutical Company Profiles
14.10.2 Kunming Pharmaceutical Product Introduction
14.10.3 Kunming Pharmaceutical Malaria Drugs Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Malaria Drugs Industry (Volume)
Figure 2. Malaria Drugs Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Malaria Drugs Revenue in 2022
Figure 5. US Malaria Drugs Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Malaria Drugs Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Malaria Drugs Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Malaria Drugs Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Malaria Drugs Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Malaria Drugs Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Malaria Drugs Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Malaria Drugs Revenue, by Type (Million USD) (2018-2028)
Table 4. Malaria Drugs Production, by Type (K Unit) (2018-2028)
Table 5. Malaria Drugs Demand (K Unit) by Application (2018-2028)
Table 6. Malaria Drugs Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Malaria Drugs Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Malaria Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Malaria Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Malaria Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Malaria Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Malaria Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Malaria Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Malaria Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Malaria Drugs in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Malaria Drugs in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Malaria Drugs in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Malaria Drugs in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Malaria Drugs in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Malaria Drugs in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Malaria Drugs in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Cipla Profiles
Table 61. Cipla Malaria Drugs Product Introduction
Table 62. Cipla Malaria Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Cipla Strategic initiatives
Table 64. Guilin Pharmaceutical Profiles
Table 65. Guilin Pharmaceutical Malaria Drugs Product Introduction
Table 66. Guilin Pharmaceutical Malaria Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Guilin Pharmaceutical Strategic initiatives
Table 68. IPCA Laboratories Profiles
Table 69. IPCA Laboratories Malaria Drugs Product Introduction
Table 70. IPCA Laboratories Malaria Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. IPCA Laboratories Strategic initiatives
Table 72. GlaxoSmithKline Profiles
Table 73. GlaxoSmithKline Malaria Drugs Product Introduction
Table 74. GlaxoSmithKline Malaria Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. GlaxoSmithKline Strategic initiatives
Table 76. Mylan Labs Profiles
Table 77. Mylan Labs Malaria Drugs Product Introduction
Table 78. Mylan Labs Malaria Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Mylan Labs Strategic initiatives
Table 80. Roche Profiles
Table 81. Roche Malaria Drugs Product Introduction
Table 82. Roche Malaria Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Roche Strategic initiatives
Table 84. Novartis Profiles
Table 85. Novartis Malaria Drugs Product Introduction
Table 86. Novartis Malaria Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Novartis Strategic initiatives
Table 88. Sanofi Aventis Profiles
Table 89. Sanofi Aventis Malaria Drugs Product Introduction
Table 90. Sanofi Aventis Malaria Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Sanofi Aventis Strategic initiatives
Table 92. Ajanta Pharma Profiles
Table 93. Ajanta Pharma Malaria Drugs Product Introduction
Table 94. Ajanta Pharma Malaria Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Ajanta Pharma Strategic initiatives
Table 97. Kunming Pharmaceutical Profiles
Table 98. Kunming Pharmaceutical Malaria Drugs Product Introduction
Table 99. Kunming Pharmaceutical Malaria Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Kunming Pharmaceutical Strategic initiatives